{
    "title": "Gilead increases enrollment target for remdesivir trial in COVID-19 patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8231291/Gilead-increases-enrollment-target-remdesivir-trial-COVID-19-patients.html",
    "date": "2020-04-17",
    "keywords": [
        "trial",
        "covid19",
        "drug",
        "company",
        "friday",
        "enrollment",
        "remdesivir",
        "report",
        "access",
        "analyst",
        "year",
        "target",
        "day",
        "news",
        "website",
        "stat",
        "recovery",
        "fever",
        "respiratory",
        "university",
        "medicine",
        "hospital",
        "estimate",
        "run",
        "gilead",
        "httpsclinicaltrialsgovct2shownct04292899termremdesivirampdraw2amprank3",
        "register",
        "brokerage",
        "piper",
        "sandler",
        "rationale",
        "increase",
        "comment",
        "enrolment",
        "system",
        "compassionateuse",
        "novel",
        "coronavirus",
        "investor",
        "attention",
        "caution",
        "thursday",
        "totality",
        "data",
        "study",
        "end",
        "month",
        "article",
        "picture",
        "exuberance",
        "lack",
        "analysis",
        "brian",
        "skorney",
        "wall",
        "street",
        "president",
        "economy",
        "production",
        "benchmark",
        "index",
        "noon",
        "trading",
        "doubt",
        "validity",
        "set",
        "halley",
        "treatment",
        "bengaluru",
        "editing",
        "kalluvila",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}